CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Spyros Nikas - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Spyros Nikas

OPENALEX: A5061917163↗ORCID: 0000-0001-5052-5292↗

Affiliations

Organizations

Northeastern Universityauthorship · US

Public evidence

6 connected articles

Comparison of Agonist Activity between CB1 and CB2 Receptors with Orthosteric Site Mutations.2024 · Europe PMC Structural basis of Δ9-THC analog activity at the Cannabinoid 1 receptor2024 · PubMed Central Open Access Structural basis for activation of CB1 by an endocannabinoid analog.2023 · Europe PMC Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats.2022 · Europe PMC Synthesis of Functionalized Cannabilactones.2020 · Europe PMC Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor.2019 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.